PatientsVille.com Logo

PatientsVille

Jolivette Side Effects

Common Jolivette Side Effects


The most commonly reported Jolivette side effects (click to view or check a box to report):

Suppressed Lactation (1)
Unintended Pregnancy (1)
Product Quality Issue (1)
Pregnancy On Oral Contraceptive (1)
Maternal Exposure During Pregnancy (1)
Breast Enlargement (1)


If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Jolivette Side Effects Reported to FDA

The following Jolivette reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Jolivette on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Maternal Exposure During Pregnancy, Pregnancy On Oral Contraceptive, Product Quality Issue
This is a report of a 31-year-old female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: unintended pregnancy, who was treated with Jolivette (dosage: 0.35mg, start time: Apr 15, 2010), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Maternal Exposure During Pregnancy
  • Pregnancy On Oral Contraceptive
  • Product Quality Issue
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Jolivette treatment in female patients, resulting in maternal exposure during pregnancy side effect.

Suppressed Lactation
This report suggests a potential Jolivette Watson Pharmaceuticals Suppressed Lactation side effect(s) that can have serious consequences. A female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: oral contraception and used Jolivette Watson Pharmaceuticals (dosage: 1 Pill Sid) starting Jul 08, 2010. Soon after starting Jolivette Watson Pharmaceuticals the patient began experiencing various side effects, including:
  • Suppressed Lactation
Drugs used concurrently: NA. Although Jolivette Watson Pharmaceuticals demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as suppressed lactation, may still occur.

Breast Enlargement
This Breast Enlargement problem was reported by a consumer or non-health professional from UNITED STATES. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: contraception. On Jun 26, 2009 this consumer started treatment with Jolivette Watson (dosage: 1 Qd Po). The following drugs were being taken at the same time: NA. When commencing Jolivette Watson, the patient experienced the following unwanted symptoms/side effects:
  • Breast Enlargement
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as breast enlargement, may become evident only after a product is in use by the general population.

Unintended Pregnancy
This is a report of a 21-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Jolivette (norethisterone) Tablets (dosage: 1 Dose(s), 1 In 1 Day, Oral) starting Mar 03, 2007. Concurrently used drugs:
  • Minocycline Hcl (90 Mg, 1 In 1 Day, Oral)
  • Tretinoin
Soon after that, the consumer experienced the following side effects:
  • Unintended Pregnancy
This opens a possibility that Jolivette (norethisterone) Tablets treatment could cause the above reactions, including unintended pregnancy, and some female subjects may be more susceptible.



Top 10 Jolivette Side Effects for Men

Men Side EffectsReports

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Jolivette Side Effects

    Did You Have a Jolivette Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Jolivette for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Jolivette Safety Alerts, Active Ingredients, Usage Information

    NDC52544-892
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameJolivette
    NameNORETHINDRONE
    Dosage FormTABLET
    RouteORAL
    On market since20030301
    LabelerActavis Pharma, Inc.
    Active Ingredient(s)NORETHINDRONE
    Strength(s)0.35
    Unit(s)mg/1
    Pharma ClassProgesterone Congeners [Chemical/Ingredient],Progestin [EPC]

    More About Jolivette

    Side Effects reported to FDA: 4

    Jolivette safety alerts: No

    Latest Jolivette clinical trials